Red X iconGreen tick iconYellow tick icon

Contact Details

Email
katharina.robichon@otago.ac.nz
Position
Lecturer
Department
Department of Pathology and Molecular Medicine (Wellington)
Qualifications
MBiotech (UF), MSc (UDS), PhD (UHEI)
Research summary
Immunologist, specialised in autoimmune diseases, with a trained background in viral infections

Research

Research details:

  • Autoimmune diseases
  • Adaptive immunology
  • Viral infections
  • Flow cytometry

Publications

Sondhauss, S., Kiernan, M., Morizzi, J., Wright, P., Prisinzano, T. E., Kivell, B. M., Robichon, K., & La Flamme, A. C. (2026). Development and application of an LC-MS method for the pharmacokinetics and pharmacodynamics of oral therapeutic efficacy of nalfurafine. Basic & Clinical Pharmacology & Toxicology, 138, e70178. doi: 10.1111/bcpt.70178 Journal - Research Article

Denny, L., Robichon, K., Templeton, N., Kiernan, M., Prisinzano, T. E., Kivell, B. M., & La Flamme, A. C. (2025). Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis. Clinical & Translational Immunology, 14(12), e70069. doi: 10.1002/cti2.70069 Journal - Research Article

Robichon, K., Taylor, J., Milner, I., Hally, K. E., & La Flamme, A. C. (2025). Monitoring treatment-associated receptor expression in multiple sclerosis using a newly developed panel for spectral flow cytometry. Cytometry Part A, 107(10), 668-682. doi: 10.1002/cyto.a.24963 Journal - Research Article

Robichon, K. (2023, February). Analysis of receptor abundances in multiple sclerosis to determine treatment regime. Verbal presentation at the Maurice Wilkins Centre (MWC) for Molecular Biodiversity Symposium, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Robichon, K., Bibi, R., Kiernan, M., Denny, L., Prisinzano, T. E., Kivell, B. M., & La Flamme, A. C. (2023). Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune-driven demyelination. Clinical & Translational Immunology, 12, e1480. doi: 10.1002/cti2.1480 Journal - Research Article

Back to top